Chimeric transcript discovery by paired-end transcriptome sequencing
Open accessThe DOI matches its Crossref record; 27 of the 29 references it cites were found in a registry or an index.
Abstract
Recurrent gene fusions are a prevalent class of mutations arising from the juxtaposition of 2 distinct regions, which can generate novel functional transcripts that could serve as valuable therapeutic targets in cancer. Therefore, we aim to establish a sensitive, high-throughput methodology to comprehensively catalog functional gene fusions in cancer by evaluating a paired-end transcriptome sequencing strategy. Not only did a paired-end approach provide a greater dynamic range in comparison with single read based approaches, but it clearly distinguished the high-level “driving” gene fusions, such as BCR-ABL1 and TMPRSS2-ERG , from potential lower level “passenger” gene fusions. Also, the comprehensiveness of a paired-end approach enabled the discovery of 12 previously undescribed gene fusions in 4 commonly used cell lines that eluded previous approaches. Using the paired-end transcriptome sequencing approach, we observed read-through mRNA chimeras, tissue-type restricted chimeras, converging transcripts, diverging transcripts, and overlapping mRNA transcripts. Last, we successfully used paired-end transcriptome sequencing to detect previously undescribed ETS gene fusions in prostate tumors. Together, this study establishes a highly specific and sensitive approach for accurately and comprehensively cataloguing chimeras within a sample using paired-end transcriptome sequencing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Over the last two years, with the further confirmation that the relatively short reads can be effectively assembled [15], especially with the great advantage of paired-end sequencing [54], the Illumina transcriptome or whole genome de novo sequencing and assembly have been successfully used for model [12,16,55-58]and non-model organisms [25-27,59].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008) · Nature Methods · doi:10.1038/nmeth.1226 · Cited by 13,696 · cited 1×
“Although current RNA sequencing (RNA-Seq) studies have been using 36-nt single reads (16, 17), we increased the likelihood of spanning a fusion junction by generating 100-nt long single reads using the Illumina Genome Analyzer II.”
MethodIdentification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Soda, M., Choi, Y. L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., Fujiwara, S.-I., Watanabe, H., Kurashina, K., Hatanaka, H., et al. (2007) · Nature · doi:10.1038/nature05945 · Cited by 5,439 · cited 1×
“However, the recent discovery of a recurrent gene fusion, TMPRSS2-ERG, in a majority of prostate cancers (5, 6), and EML4-ALK in non-small-cell lung cancer (NSCLC) (7), has expanded the realm of gene fusions as an oncogenic mechanism in common solid cancers.”
BackgroundRecurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Self-citationFive-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Druker, B. J., Guilhot, F., O'Brien, S. G., Gathmann, I., Kantarjian, H., Gattermann, N., Deininger, M. W. N., Silver, R. T., Goldman, J. M., Stone, R. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062867 · Cited by 3,488
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J.-P., Tong, F., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,188
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184 · cited 1×
“O of the most common classes of genetic alterations is gene fusions, resulting from chromosomal rearrangements (1).”
BackgroundEffects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. B. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 2,967
RNA-seq: An assessment of technical reproducibility and comparison with gene expression arrays
Marioni, J. C., Mason, C. E., Mane, S. M., Stephens, M., & Gilad, Y. (2008) · Genome Research · doi:10.1101/gr.079558.108 · Cited by 2,771
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
Kantarjian, H., Sawyers, C., Hochhaus, A., Guilhot, F., Schiffer, C., Gambacorti-Passerini, C., Niederwieser, D., Resta, D., Capdeville, R., Zoellner, U., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011573 · Cited by 2,019
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
Shtivelman, E., Lifshitz, B., Gale, R. P., & Canaani, E. (1985) · Nature · doi:10.1038/315550a0 · Cited by 1,611
Cited by
Items 201–300 of 383
Fast and sensitive validation of fusion transcripts in whole-genome sequencing data
Hafstað, V., Häkkinen, J., & Persson, H. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05489-5 · Cited by 21
RNA-seq Using Next Generation Sequencing
Corney, D. C. (2012) · Materials and Methods · doi:10.13070/mm.en.2.203 · Cited by 21
Panagopoulos, I., Thorsen, J., Gorunova, L., Micci, F., & Heim, S. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.05.018 · Cited by 21
Statistical algorithms improve accuracy of gene fusion detection
Hsieh, G. L., Bierman, R., Szabo, L. A., Lee, A. G., Freeman, D. E., Watson, N. K., Sweet-Cordero, A., & Salzman, J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx453 · Cited by 21
Poly (A)+ Transcriptome Assessment of ERBB2-Induced Alterations in Breast Cell Lines
Carraro, D. M., Ferreira, E. N., Molina, G. D. C., Puga, R., Abrantes, E. F., Trapé, A. P., Ekhardt, B. L., Nunes, D. N., Brentani, M. M., Arap, W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021022 · Cited by 20
Interrogating genomic and epigenomic data to understand prostate cancer
Kim, J., & Yu, J. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.12.003 · Cited by 20
Self-citationYang, Y., Tang, Z., Fan, X., Xu, K., Mu, Y., Zhou, R., & Li, K. (2016) · Scientific Reports · doi:10.1038/srep29039 · Cited by 20
Fusion gene microarray reveals cancer type‐specificity among fusion genes
Løvf, M., Thomassen, G. O. S., Bakken, A. C., Celestino, R., Fioretos, T., Lind, G. E., Lothe, R. A., & Skotheim, R. I. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20860 · Cited by 20
Yuan, C., Han, Y., Zellmer, L., Yang, W., Guan, Z., Yu, W., Huang, H., & Liao, D. J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040714 · Cited by 20
High-throughput detection of fusion genes in cancer using the Sequenom MassARRAY platform
Lambros, M. B. K., Wilkerson, P. M., Natrajan, R., Patani, N., Pawar, V. S., Vatcheva, R., Mansour, M. B., Laschet, M., Oelze, B., Orr, N., et al. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.110 · Cited by 20
Pflueger, D., Mittmann, C., Dehler, S., Rubin, M. A., Moch, H., & Schraml, P. (2015) · BMC Genomics · doi:10.1186/s12864-015-1446-z · Cited by 20
Hampton, O. A., Miller, C. A., Koriabine, M., Li, J., den Hollander, P., Carbone, L., Nefedov, M. D., ten Hallers, B., Lee, A. V., de Jong, P. J., et al. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.07.009 · Cited by 19
Chimeric RNAs as potential biomarkers for tumor diagnosis
Zhou, J.-H., Liao, J., Zheng, X., & Shen, H. (2012) · BMB Reports · doi:10.5483/bmbrep.2012.45.3.133 · Cited by 19
Recurrent Rearrangements in Prostate Cancer: Causes and Therapeutic Potential
White, N. M. A., Feng, F. Y.-C., & Maher, C. A. (2013) · Current Drug Targets · doi:10.2174/1389450111314040006 · Cited by 19
Self-citationChen, C.-Y., & Chuang, T. (2019) · BMC Bioinformatics · doi:10.1186/s12859-018-2589-0 · Cited by 19
Fusion transcript loci share many genomic features with non-fusion loci
Bioresource, A. P. C., Lai, J., An, J., Seim, I., Walpole, C., Hoffman, A., Moya, L., Srinivasan, S., Perry‐Keene, J., Wang, C., et al. (2015) · BMC Genomics · doi:10.1186/s12864-015-2235-4 · Cited by 18
Mittal, V. K., & McDonald, J. F. (2017) · BMC Medical Genomics · doi:10.1186/s12920-017-0289-7 · Cited by 18
Zhou, L., Chen, F., Pan, H., Ye, J., Dong, X., Li, C., & Lin, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091492 · Cited by 18
Soft tissue sarcomas—New approaches to diagnosis and classification
Lauer, S. R., & Gardner, J. M. (2013) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2013.03.001 · Cited by 17
Sequencing the transcriptional network of androgen receptor in prostate cancer
Chng, K. R., & Cheung, E. C. W. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.009 · Cited by 17
Xu, X., Yang, Y., Li, H., Chen, Z., Jiang, G., & Fei, K. (2016) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2016.1183813 · Cited by 17
Personalized medicine in hematology — A landmark from bench to bed
Badalian‐Very, G. (2014) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2014.08.002 · Cited by 17
Detection of a common chimeric transcript between human chromosomes 7 and 16
Fang, W., Wei, Y., Kang, Y., & Landweber, L. F. (2012) · Biology Direct · doi:10.1186/1745-6150-7-49 · Cited by 17
TMPRSS2-ERG gene fusion in prostate cancer
Burdová, A., Bouchal, J., Tavandzis, S., & Kolář, Z. (2014) · Biomedical Papers · doi:10.5507/bp.2014.065 · Cited by 16
Genetic Alterations Targeting Lymphoid Development in Acute Lymphoblastic Leukemia
Collins-Underwood, J. R., & Mullighan, C. G. (2011) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-380916-2.00006-1 · Cited by 15
Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations
Patacsil, D., Miya, J., Reeser, J. W., & Roychowdhury, S. (2016) · Journal of Visualized Experiments · doi:10.3791/54090 · Cited by 15
Novel transcription-induced fusion RNAs in prostate cancer
Zhao, S., Løvf, M., Carm, K. T., Bakken, A. C., Hoff, A., & Skotheim, R. I. (2017) · Oncotarget · doi:10.18632/oncotarget.17099 · Cited by 15
Casado‐Vela, J., Lacal, J. C., & Elortza, F. (2012) · PROTEOMICS · doi:10.1002/pmic.201200371 · Cited by 14
The structure of state-of-art gene fusion-finder algorithms
Beccuti, M., Carrara, M., Cordero, F., Donatelli, S., & Calogero, R. (2013) · OA Bioinformatics · doi:10.13172/2054-1899-1-1-617 · Cited by 14
New chimeric RNAs in acute myeloid leukemia
Rufflé, F., Audoux, J., Boureux, A., Beaumeunier, S., Gaillard, J., Samra, E. B., Mégarbané, A., Cassinat, B., Chomienne, C., Alves, R. C. D. O., et al. (2017) · F1000Research · doi:10.12688/f1000research.11352.1 · Cited by 14
Inversion-mediated gene fusions involving NAB2-STAT6 in an unusual malignant meningioma
Gao, F., Ling, C., Shi, L., Commins, D., Zada, G., Mack, W. J., & Wang, K. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.395 · Cited by 14
Liu, G., Xu, M., Chang, Q., Gao, J., Wang, C., & Zhu, X. (2016) · Parasites & Vectors · doi:10.1186/s13071-016-1436-2 · Cited by 14
Navaei, A., Walter, B. A., Moreno, V., Pack, S., Pinto, P. A., & Merino, M. J. (2017) · Journal of Cancer · doi:10.7150/jca.16751 · Cited by 14
Oncogenic Effect of the Novel Fusion Gene VAPA-Rab31 in Lung Adenocarcinoma
Yoon, D., Bae, K., Kim, J.-H., Choi, Y., & Yoon, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092309 · Cited by 13
Harms, P. W., Hristov, A. C., Kim, D., Anens, T., Quist, M. J., Siddiqui, J., Carskadon, S. L., Mehra, R., Fullen, D. R., Johnson, T. M., et al. (2014) · Human Pathology Case Reports · doi:10.1016/j.ehpc.2014.07.002 · Cited by 13
Self-citationDisrupted in renal carcinoma 2 (DIRC2/SLC49A4) is an H+-driven lysosomal pyridoxine exporter
Akino, S., Yasujima, T., Yamashiro, T., & Yuasa, H. (2022) · Life Science Alliance · doi:10.26508/lsa.202201629 · Cited by 12
Meyer, C. A., Tang, Q., & Liu, X. S. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1150 · Cited by 12
Applications of Second Generation Sequencing Technologies in Complex Disorders
Bayés, M., Heath, S. C., & Gut, I. G. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_196 · Cited by 12
Shanmuganathan, N., Wadham, C., Thomson, D. W., Shahrin, N. H., Vignaud, C., Obourn, V., Chaturvedi, S., Yang, F. J., Feng, J., Saunders, V. A., et al. (2022) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2022.04.004 · Cited by 11
Wang, A., Shu, X., Niu, X., Yi, X., & Zheng, A. (2019) · Journal of Plant Pathology · doi:10.1007/s42161-019-00401-8 · Cited by 11
The Significance of Transcriptome Sequencing in Personalized Cancer Medicine
Zhang, S., Wei, J. S., & Khan, J. I. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-396967-5.00004-9 · Cited by 11
Mutational Events in Lung Cancer
Morgensztern, D., Devarakonda, S. H. K., Mitsudomi, T., Maher, C. A., & Govindan, R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-52357-8.00011-1 · Cited by 11
Self-citationWang, L. (2013) · Frontiers of Medicine · doi:10.1007/s11684-013-0265-3 · Cited by 9
De novo assembly of Phlomis purpurea after challenging with Phytophthora cinnamomi
Baldé, A., Neves, D., García-Breijo, F., Pais, M. S., & Cravador, A. (2017) · BMC Genomics · doi:10.1186/s12864-017-4042-6 · Cited by 8
TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma.
Xu, Y., Rao, Q., Xia, Q., Shi, S., Shi, Q.-L., Ma, H., Lu, Z., Chen, H., & Zhou, X. (2015) · PubMed · Cited by 8
Androgen Regulation of ETS Gene Fusion Transcripts in Prostate Cancer
Tandefelt, D. G., & Trapman, J. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-243-4_19 · Cited by 7
Gene Biomarkers Derived from Clinical Data of Hepatocellular Carcinoma
Qi, J., Zhou, J., Tang, X.-Q., & Wang, Y. (2020) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-020-00366-8 · Cited by 7
Whole-transcriptome analysis of hepatocellular carcinoma
Lin, L., Wang, D., Cao, N., Lin, Y., Yu, J. H., & Zheng, C.-Q. (2013) · Medical Oncology · doi:10.1007/s12032-013-0736-z · Cited by 6
Self-citationClinical Efficacy and Possible Applications of Genomics in Lung Cancer
Alharbi, K. K. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.5.1693 · Cited by 6
Fu, Y., Jia, L., Shi, Z., Zhang, J., & Li, W. (2017) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2017.01.003 · Cited by 6
Mittal, V. K., & McDonald, J. F. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks047 · Cited by 6
The novel fusion transcript NR5A2‐KLHL29FT is generated by an insertion at the KLHL29 locus
Sun, Z., Ke, X., Salzberg, S. L., Kim, D., Antonescu, V., Cheng, Y., Huang, B., Song, J. H., Abraham, J. M., Ibrahim, S., et al. (2017) · Cancer · doi:10.1002/cncr.30510 · Cited by 6
Data structures and algorithms for analysis of alternative splicing with RNA- seq data
Schulz, M. H. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-16841 · Cited by 7
Role of Transcriptomics in Precision Oncology
Srivastava, R. (2024) · Reports of Radiotherapy and Oncology · doi:10.5812/rro-142195 · Cited by 5
Chen, X., Houten, S. M., Allette, K., Sebra, R., Stolovitzky, G. A., & Losic, B. (2017) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789813235533_0002 · Cited by 5
Badai, S. S. (2019) · Journal of Oil Palm Research · doi:10.21894/jopr.2019.0022 · Cited by 5
Wang, B., Hu, H. K., Gao, R., Wang, G., & Jiang, T. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf702 · Cited by 3
Clonotyping for precision oncology
Dang, H. X., & Maher, C. A. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.10.010 · Cited by 3
Self-citationVats, P., Chinnaiyan, A. M., & Kumar‐Sinha, C. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9904-0_5 · Cited by 3
Self-citationTechniques for Analyzing Genome-wide Expression of Non-coding RNA
Onoguchi‐Mizutani, R., Taniue, K., Kawata, K., Yamada, T., & Akimitsu, N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91909-8.00039-6 · Cited by 3
Panagopoulos, I. (2015) · Wiley eBooks · doi:10.1002/9781118795569.ch5 · Cited by 3
RNA-Sequencing and Methylome Analysis
Ketkar, S., & Kulkarni, S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404748-8.00006-x · Cited by 3
Buscher, D. F., & Longair, M. S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781107323933.013 · Cited by 3
Roach, C. R. (2018) · cIRcle (University of British Columbia) · doi:10.14288/1.0357455 · Cited by 3
Identification of Neo-antigens for a Cancer Vaccine by Transcriptome Analysis
(2012) · Arizona State University Library Digital Repository (Arizona State University) · Cited by 3
Frenkel‐Morgenstern, M. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9904-0_3 · Cited by 2
Bin, 杨. Y., Shuhua, 岳. Y., & Pu, 王. W. (2024) · Chinese Journal of Lasers · doi:10.3788/cjl240447 · Cited by 2
Cancer Transcriptome Sequencing and Analysis
Morin, R. D., & Montgomery, S. B. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-396967-5.00003-7 · Cited by 2
Moving Towards Third‐Generation Sequencing Technologies
Janitz, K., & Janitz, M. (2011) · Wiley eBooks · doi:10.1002/9783527644582.ch20 · Cited by 2
Twenty-First Century Pathology Sign-Out
Tomlins, S. A., Robinson, D., Penny, R. J., & Hess, J. L. (2012) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2012.07.002 · Cited by 2
Transcriptomics Using Axolotls
Voss, S. R., Athippozhy, A., & Woodcock, M. R. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2495-0_24 · Cited by 2
Systematic Assessment of RNA-Seq Quantification Tools Using Simulated Sequence Data
Chandramohan, R., Wu, P.-Y., Phan, J. H., & Wang, M. D. (2013) · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB) · doi:10.1145/2506583.2506648 · Cited by 2
Molecular Pathology of Prostate Cancer
Udager, A. M., Smith, S. C., & Tomlins, S. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800886-7.00022-4 · Cited by 2
Gene Fusion Discovery with INTEGRATE
Zhang, J., & Maher, C. A. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9904-0_4 · Cited by 2
Self-citationTechnological Advances in the Detection of Novel Fusion Genes
Leow, P. C., Ku, C., Soo, R. A., & Soong, R. C. T. (2012) · Wiley eBooks · doi:10.1002/9780470015902.a0023916 · Cited by 2
1074 Microseminoprotein-beta expression in different stages of prostate cancer
Sjöblom, L., Saramäki, O. R., Annala, M., Leinonen, K. A., Nättinen, J. E., Tolonen, T. T., Wahlfors, T., Nykter, M., Bova, G. S., Schleutker, J., et al. (2016) · European Urology Supplements · doi:10.1016/s1569-9056(16)61075-8 · Cited by 2
Rinckleb, A. E. (2014) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-3439 · Cited by 2
The Role of Long Noncoding RNA SChLAP1 in Prostate Cancer
Sahu, A. (2015) · Deep Blue (University of Michigan) · Cited by 2
Philippe, N. (2011) · theses.fr (ABES) · doi:10.70675/61f0bd4dzc25az4991z9d80z68f70d9a3df2 · Cited by 2
Cancer Cytogenetics: Deep Roots, New Branches in the Age of Omics
Panagopoulos, I. (2026) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20580 · Cited by 1
Cancer Sequencing Gets a Little More Personal
Prokunina‐Olsson, L., & Chanock, S. J. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000929 · Cited by 1
Gene Fusions in Prostate Cancer
McDaniel, A. S., & Tomlins, S. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-19983-2_17 · Cited by 1
Terzo, O., Mossucca, L., Acquaviva, A., Abate, F., Ficarra, E., & Provenzano, R. (2012) · PORTO@Iris · Cited by 1
Virtual Environment for Next Generation Sequencing Analysis
Terzo, O., Mossucca, L., Acquaviva, A., Abate, F., & Provenzano, R. (2012) · PORTO@Iris · Cited by 1
Reverse Engineering of TopHat: Splice Junction Mapper for Improving Computational Aspect
Terzo, O., Mossucca, L., Acquaviva, A., Abate, F., Ficarra, E., & Provenzano, R. (2012) · International Conference on Intelligent Systems, Modelling and Simulation · doi:10.1109/isms.2012.76 · Cited by 1
The Application of the Next-Generation Sequencing Technologies in Cancer Research
Cheng, L., Xu, H., & Lin, B. (2012) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814324465_0012 · Cited by 1
Eldein, M. M. N., Nasif, W. A., Nasif, W. A., Amin, A. A., Modawe, G. A., & Babakr, A. T. (2024) · Sudan Journal of Medical Sciences · doi:10.18502/sjms.v19i1.15764 · Cited by 1
High-throughput RNA sequencing: a step forward in transcriptome analysis
Okonechnikov, K. (2016) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-13309 · Cited by 1
Klevebring, D. (2013) · Springer eBooks · doi:10.1007/978-1-4419-9863-7_101543 · Cited by 1
Identification of biomarkers for the management of human prostate cancer
Luca, B. A. (2017) · UEA Digital Repository (University of East Anglia) · Cited by 1
Genetic Susceptibility and Molecular Characterization of Glioma
Labrèche, K. (2018) · theses.fr (ABES) · doi:10.70675/fd6e0150z27bdz427cz8017z5886c168af6b · Cited by 1
Sun, W., Guo, J., Cheng, Z., Zhang, Y., & Gao, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1122595/v1 · Cited by 1
Expression and Function of ETS Genes in Prostate Cancer
Tandefelt, D. G. (2013) · RePub (Erasmus University Rotterdam) · Cited by 1
Tavakoli, A. (2013) · Scholarship at UWindsor (University of Windsor) · Cited by 2
Oncogenic Fusion Transcripts in Pediatric Papillary Thyroid Carcinomas
Stosic, A. (2020) · TSpace (University of Toronto) · Cited by 1
Integrated modelling of lipid metabolism in Plasmodium, the causative parasite of malaria
Sen, P. (2013) · theses.fr (ABES) · doi:10.70675/5206dff9zcbb4z4943z9689z2f91465d15d3 · Cited by 1
Radovich, M. (2012) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1947 · Cited by 1
Somatic Mutations in Breast Cancer Genomes : Discovery and Validation of Breast Cancer Genes
Jiao, X. (2012) · Uppsala University Publications (Uppsala University) · Cited by 1
A NOVEL ANALYSIS FLOW FOR FUSED TRANSCRIPTS DISCOVERY FROM PAIRED-END RNA-SEQ DATA
Abate, F., Paciello, G., Acquaviva, A., Ficarra, E., Ferrarini, A., Delledonne, M., & Macii, E. (2012) · International Conference on Bioinformatics Models, Methods and Algorithms (BIOINFORMATICS) · doi:10.5220/0003789003310334
Metadata
- Authors
- Maher, C. A., Palanisamy, N., Brenner, J. C., Cao, X., Kalyana-Sundaram, S., Luo, S., Khrebtukova, I., Barrette, T. R., Grasso, C., Yu, J., Lonigro, R. J., Schroth, G., Kumar-Sinha, C., & Chinnaiyan, A. M.
- Affiliations
- Michigan Center for Translational Pathology (US)
- University of Michigan (US)
- Michigan Center for Translational Pathology, Ann Arbor, MI 48109;
- Illumina (United States) (US)
- Howard Hughes Medical Institute (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-07-28
- Volume
- 106
- Issue
- 30
- Pages
- 12353-12358
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2708976
- OpenAlex
- W2169810552
- Cited by
- 339
- References
- 29
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 7 · 2022: 6 · 2021: 7 · 2020: 15 · 2019: 13 · 2018: 11 · 2017: 24 · 2016: 21 · 2015: 28 · 2014: 27 · 2013: 41 · 2012: 49
- FWCI
- 17.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute on Drug Abuse (U54DA021519)
- National Cancer Institute (P50-CA-69568, R01CA132874, U01CA111275, K99CA129565, P50CA069568)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- gene fusion, fusion transcripts, BCR-ABL1, TMPRSS2-ERG fusion, ETS gene fusions, prostate cancer, cancer mutations
- MeSH terms
- Base Sequence, Humans, Male, Molecular Sequence Data, Neoplasms, Prostatic Neoplasms, RNA, Messenger, Transcription, Genetic, Oncogene Proteins, Fusion, Gene Expression Regulation, Neoplastic, Fusion Proteins, bcr-abl, Sequence Analysis, DNA, K562 Cells, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.